Dysfunctions in multiple interrelated systems as the neurobiological bases of schizophrenic symptom clusters.

The absence of an animal model that accurately approximates schizophrenia limits current research into the pathophysiology of this disorder. Obviously, the cognitive disturbances associated with schizophrenia are difficult to evaluate in laboratory animals. Nonetheless, animal studies have provided insight into the anatomy and physiology of the brain systems that have been implicated in schizophrenia. These studies also suggest how brain systems may be involved in information processing in normal and pathological conditions. Thus, a careful assessment of the properties and functions of the brain regions suggested to be involved in schizophrenic symptoms has been a primary objective in several laboratories. In this review, we discuss the interactions among the brain regions implicated in schizophrenia--the ventral striatum, prefrontal cortex, hippocampus, and dopamine systems--and provide an integrative model linking altered function in these regions with specific clusters of symptoms of schizophrenia.

[1]  M. Merello,et al.  [Functional anatomy of the basal ganglia]. , 2000, Revista de neurologia.

[2]  A. Grace,et al.  Interconnected Parallel Circuits between Rat Nucleus Accumbens and Thalamus Revealed by Retrograde Transynaptic Transport of Pseudorabies Virus , 1997, The Journal of Neuroscience.

[3]  Anthony A. Grace,et al.  Dopamine-cell depolarization block as a model for the therapeutic actions of antipsychotic drugs , 1997, Trends in Neurosciences.

[4]  E. Bullmore,et al.  Society for Neuroscience Abstracts , 1997 .

[5]  A. Grace,et al.  Cortical afferents modulate striatal gap junction permeability via nitric oxide , 1996, Neuroscience.

[6]  H. C. Cromwell,et al.  Neuromodulatory actions of dopamine on synaptically‐evoked neostriatal responses in slices , 1996 .

[7]  A. Grace,et al.  Dopaminergic Reduction of Excitability in Nucleus Accumbens Neurons Recorded in Vitro , 1996, Neuropsychopharmacology.

[8]  J. Yao,et al.  Dopamine Turnover in Schizophrenia Before and after Haloperidol Withdrawal , 1996, Neuropsychopharmacology.

[9]  J. Harvey,et al.  Endogenous and exogenous dopamine depress EPSCs in rat nucleus accumbens in vitro via D1 receptors activation. , 1996, The Journal of physiology.

[10]  Charles J. Wilson,et al.  The origins of two-state spontaneous membrane potential fluctuations of neostriatal spiny neurons , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[11]  P. Renshaw,et al.  Proton magnetic resonance spectroscopy of the temporal lobes in schizophrenics and normal controls , 1996, Schizophrenia Research.

[12]  R. Malenka,et al.  Psychostimulants depress excitatory synaptic transmission in the nucleus accumbens via presynaptic D1-like dopamine receptors , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[13]  P. Renshaw,et al.  Functional magnetic resonance imaging of schizophrenic patients and comparison subjects during word production. , 1996, The American journal of psychiatry.

[14]  E. Williams,et al.  Ventral striatopallidothalamic projection: IV. Relative involvements of neurochemically distinct subterritories in the ventral pallidum and adjacent parts of the rostroventral forebrain , 1996, The Journal of comparative neurology.

[15]  W. Honer,et al.  A case study of temporal lobe development in familial schizophrenia , 1996, Psychological Medicine.

[16]  R I Grossman,et al.  Frontal and temporal lobe brain volumes in schizophrenia. Relationship to symptoms and clinical subtype. , 1995, Archives of general psychiatry.

[17]  J. Olney,et al.  Glutamate receptor dysfunction and schizophrenia. , 1995, Archives of general psychiatry.

[18]  K. Fuxe,et al.  Intercellular communication in the brain: Wiring versus volume transmission , 1995, Neuroscience.

[19]  S. Daviss,et al.  Local circuit neurons of the prefrontal cortex in schizophrenia: selective increase in the density of calbindin-immunoreactive neurons , 1995, Psychiatry Research.

[20]  R. Kerwin,et al.  Schizophrenic auditory hallucinations are associated with increased regional cerebral blood flow during verbal memory activation in a study using single photon emission computed tomography , 1995, Psychiatry Research: Neuroimaging.

[21]  Richard S. J. Frackowiak,et al.  A functional neuroanatomy of hallucinations in schizophrenia , 1995, Nature.

[22]  L. Jarrard What does the hippocampus really do? , 1995, Behavioural Brain Research.

[23]  A. Grace,et al.  Repeated treatment with haloperidol and clozapine exerts differential effects on dye coupling between neurons in subregions of striatum and nucleus accumbens , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[24]  P. Goldman-Rakic,et al.  Abnormally high neuronal density in the schizophrenic cortex. A morphometric analysis of prefrontal area 9 and occipital area 17. , 1995, Archives of general psychiatry.

[25]  J. Csernansky,et al.  Kainic acid decreases hippocampal neuronal number and increases dopamine receptor binding in the nucleus accumbens: an animal model of schizophrenia , 1995, Behavioural Brain Research.

[26]  R. Knight,et al.  Human prefrontal lesions increase distractibility to irrelevant sensory inputs , 1995, Neuroreport.

[27]  A. Grace,et al.  Different effects of subchronic clozapine and haloperidol on dye-coupling between neurons in the rat striatal complex , 1995, Neuroscience.

[28]  G D Pearlson,et al.  Reversal of asymmetry of the planum temporale in schizophrenia. , 1995, The American journal of psychiatry.

[29]  A. Grace,et al.  Synaptic interactions among excitatory afferents to nucleus accumbens neurons: hippocampal gating of prefrontal cortical input , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[30]  A. Popli,et al.  L-Dopa for schizophrenia: High time for reconsideration , 1995, Schizophrenia Research.

[31]  D. Kammen,et al.  Dopamine turnover in schizophrenia before and after haloperidol withdrawal: CSF, plasma and urine studies , 1995, Schizophrenia Research.

[32]  R Kikinis,et al.  Prefrontal cortex and schizophrenia. A quantitative magnetic resonance imaging study. , 1995, Archives of general psychiatry.

[33]  Peter Falkai,et al.  Disturbed planum temporale asymmetry in schizophrenia. A quantitative post-mortem study , 1995, Schizophrenia Research.

[34]  A. Parent,et al.  Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop , 1995, Brain Research Reviews.

[35]  C. Alzheimer,et al.  Stimulus-evoked dopamine overflow in the rat nucleus accumbens is decreased following chronic haloperidol administration: an in vivo voltammetric study , 1995, Neuroscience Letters.

[36]  J. Kleinman,et al.  Quantitative autoradiography of dopamine-D1 receptors, D2 receptors, and dopamine uptake sites in postmortem striatal specimens from schizophrenic patients , 1994, Biological Psychiatry.

[37]  John P. Stack,et al.  1H-magnetic resonance spectroscopy of the left temporal and frontal lobes in schizophrenia: Clinical, neurodevelopmental, and cognitive correlates , 1994, Biological Psychiatry.

[38]  J. Ehrhardt,et al.  Regional brain abnormalities in schizophrenia measured with magnetic resonance imaging. , 1994, JAMA.

[39]  T. Inubushi,et al.  Correlations of phosphomonoesters measured by phosphorus-31 magnetic resonance spectroscopy in the frontal lobes and negative symptoms in schizophrenia , 1994, Psychiatry Research: Neuroimaging.

[40]  W. Dimpfel,et al.  Multiunit activity from the A9 and A10 areas in rats following chronic treatment with different neuroleptic drugs , 1994, European Neuropsychopharmacology.

[41]  J. Ehrhardt,et al.  Thalamic abnormalities in schizophrenia visualized through magnetic resonance image averaging. , 1994, Science.

[42]  R. Buchanan,et al.  Neuropsychological impairments in deficit vs nondeficit forms of schizophrenia. , 1994, Archives of general psychiatry.

[43]  A. Grace,et al.  Modulation of dorsal thalamic cell activity by the ventral pallidum: Its role in the regulation of thalamocortical activity by the basal ganglia , 1994, Synapse.

[44]  P Schmalbrock,et al.  Proton Magnetic Resonance Spectroscopy (1H MRS) of the Hippocampal Formation in Schizophrenia: A Pilot Study , 1994, British Journal of Psychiatry.

[45]  A. Catafau,et al.  Prefrontal dysfunction in young acute neuroleptic-naive schizophrenic patients: A resting and activation SPECT study , 1994, Psychiatry Research: Neuroimaging.

[46]  S. Dollfus,et al.  A comparison of plasma homovanillic acid in the deficit and nondeficit subtypes of schizophrenia , 1994, Biological Psychiatry.

[47]  W. Schultz,et al.  Behavior-related activity of primate dopamine neurons. , 1994, Revue neurologique.

[48]  B. Turetsky,et al.  Frontal and temporal lobe brain volumes in schizophrenia: relationship to symptomatology and clinical subtype , 1994, Biological Psychiatry.

[49]  A. Grace,et al.  Dye coupling between rat striatal neurons recorded in vivo: compartmental organization and modulation by dopamine. , 1994, Journal of neurophysiology.

[50]  P. Stratta,et al.  Magnetic resonance imaging findings of amygdala- anterior hippocampus shrinkage in male patients with schizophrenia , 1994, Psychiatry Research.

[51]  D. Lozsádi,et al.  Organization of cortical afferents to the rostral, limbic sector of the rat thalamic reticular nucleus , 1994, The Journal of comparative neurology.

[52]  T. Skarsfeldt Comparison of short-term administration of sertindole, clozapine and haloperidol on the inactivation of midbrain dopamine neurons in the rat. , 1994, European journal of pharmacology.

[53]  Daniel R. Weinberger,et al.  Medial temporal lobe structures in schizophrenia: relationship of size to duration of illness , 1994, Schizophrenia Research.

[54]  Philip D. Harvey,et al.  Neuropsychological correlates of central monoamine function in chronic schizophrenia: relationship between CSF metabolites and cognitive function , 1994, Schizophrenia Research.

[55]  P. Goldman-Rakic,et al.  The role of D1-dopamine receptor in working memory: local injections of dopamine antagonists into the prefrontal cortex of rhesus monkeys performing an oculomotor delayed-response task. , 1994, Journal of neurophysiology.

[56]  A. Grace,et al.  Tonic D2-mediated attenuation of cortical excitation in nucleus accumbens neurons recorded in vitro , 1994, Brain Research.

[57]  M. Rao,et al.  Biochemical Findings of Negative Symptoms in Schizophrenia and Their Putative Relevance to Pharmacological Treatment , 1994 .

[58]  B. Pakkenberg,et al.  Leucotomized schizophrenics lose neurons in the mediodorsal thalamic nucleus , 1993, Neuropathology and applied neurobiology.

[59]  P. O’Donnell,et al.  Dopaminergic modulation of dye coupling between neurons in the core and shell regions of the nucleus accumbens , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[60]  H. Matsuda,et al.  SPECT analysis of regional cerebral blood flow changes in patients with schizophrenia during the Wisconsin card sorting test , 1993, Schizophrenia Research.

[61]  R. Murray,et al.  Reduction of cortical volume in schizophrenia on magnetic resonance imaging , 1993, Psychological Medicine.

[62]  L. Garey,et al.  Ultrastructural features of biopsied temporopolar cortex (area 38) in a case of schizophrenia , 1993, Schizophrenia Research.

[63]  Jeffrey A. Lieberman,et al.  Hippocampus-amygdala volumes and psychopathology in chronic schizophrenia , 1993, Biological Psychiatry.

[64]  A. Grace,et al.  Physiological and morphological properties of accumbens core and shell neurons recorded in vitro , 1993, Synapse.

[65]  G D Pearlson,et al.  Neuroimaging in schizophrenia research. , 1993, Schizophrenia bulletin.

[66]  C. Cotman,et al.  Excitatory amino acid receptors in schizophrenia. , 1993, Schizophrenia bulletin.

[67]  J. Brodie,et al.  Negative symptoms and hypofrontality in chronic schizophrenia. , 1992, Archives of general psychiatry.

[68]  R. Wise,et al.  Acute depolarization block of A10 dopamine neurons: interactions of morphine with dopamine antagonists , 1992, Brain Research.

[69]  M. LeMay,et al.  Abnormalities of the left temporal lobe and thought disorder in schizophrenia. A quantitative magnetic resonance imaging study. , 1992, The New England journal of medicine.

[70]  A. Deutch,et al.  Regionally specific effects of atypical antipsychotic drugs on striatal Fos expression: The nucleus accumbens shell as a locus of antipsychotic action , 1992, Molecular and Cellular Neuroscience.

[71]  D. Weinberger,et al.  Ibotenic acid lesion of the ventral hippocampus differentially affects dopamine and its metabolites in the nucleus accumbens and prefrontal cortex in the rat , 1992, Brain Research.

[72]  W T Carpenter,et al.  Limbic system abnormalities identified in schizophrenia using positron emission tomography with fluorodeoxyglucose and neocortical alterations with deficit syndrome. , 1992, Archives of general psychiatry.

[73]  B. Pakkenberg,et al.  The volume of the mediodorsal thalamic nucleus in treated and untreated schizophrenics , 1992, Schizophrenia Research.

[74]  D. Weinberger,et al.  Evidence of dysfunction of a prefrontal-limbic network in schizophrenia: a magnetic resonance imaging and regional cerebral blood flow study of discordant monozygotic twins. , 1992, The American journal of psychiatry.

[75]  F. H. Lopes da Silva,et al.  Presynaptic dopamine D1 receptors attenuate excitatory and inhibitory limbic inputs to the shell region of the rat nucleus accumbens studied in vitro. , 1992, Journal of neurophysiology.

[76]  Karl J. Friston,et al.  Cerebral Blood Flow and Mental Processes in Schizophrenia , 1992, Journal of the Royal Society of Medicine.

[77]  J. Sangiovanni,et al.  Increased GABAA receptor binding in superficial layers of cingulate cortex in schizophrenics , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[78]  Karl J. Friston,et al.  Patterns of Cerebral Blood Flow in Schizophrenia , 1992, British Journal of Psychiatry.

[79]  Karl J. Friston,et al.  The dorsolateral prefrontal cortex, schizophrenia and PET. , 1992, Journal of neural transmission. Supplementum.

[80]  A. Grace The depolarization block hypothesis of neuroleptic action: implications for the etiology and treatment of schizophrenia. , 1992, Journal of neural transmission. Supplementum.

[81]  A. Grace Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: A hypothesis for the etiology of schizophrenia , 1991, Neuroscience.

[82]  D. Javitt,et al.  Recent advances in the phencyclidine model of schizophrenia. , 1991, The American journal of psychiatry.

[83]  J. O. Schenk,et al.  Effects of acute and chronic systemic administration of some typical antipsychotic drugs on turnover of dopamine and potassium ion-induced release of dopamine in the striatum of the rat in vivo , 1991, Neuropharmacology.

[84]  B T Hyman,et al.  Some cytoarchitectural abnormalities of the entorhinal cortex in schizophrenia. , 1991, Archives of general psychiatry.

[85]  M. Keshavan,et al.  Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naive schizophrenics. A pilot study of the dorsal prefrontal cortex by in vivo phosphorus 31 nuclear magnetic resonance spectroscopy. , 1991, Archives of general psychiatry.

[86]  A. Scheibel,et al.  Hippocampal pyramidal cell disarray in schizophrenia as a bilateral phenomenon. , 1991, Archives of general psychiatry.

[87]  B. Mazoyer,et al.  The Estimated Density of D2 Striatal Receptors in Schizophrenia , 1991, British Journal of Psychiatry.

[88]  J. Garthwaite,et al.  NMDA receptor activation in rat hippocampus induces cyclic GMP formation through the l-arginine-nitric oxide pathway , 1991, Neuroscience Letters.

[89]  E. Gardner,et al.  Chronic treatment with clozapine selectively decreases basal dopamine release in nucleus accumbens but not in caudate-putamen as measured by in vivo brain microdialysis: Further evidence for depolarization block , 1991, Neuroscience Letters.

[90]  T. Goldberg,et al.  Cognitive and behavioral effects of the coadministration of dextroamphetamine and haloperidol in schizophrenia. , 1991, The American journal of psychiatry.

[91]  R. Kerwin,et al.  Quantitative autoradiographic analysis of glutamate binding sites in the hippocampal formation in normal and schizophrenic brain post mortem , 1990, Neuroscience.

[92]  B. Pakkenberg,et al.  Pronounced reduction of total neuron number in mediodorsal thalamic nucleus and nucleus accumbens in schizophrenics. , 1990, Archives of general psychiatry.

[93]  A. Carlsson,et al.  Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease , 1990, Trends in Neurosciences.

[94]  D. Weinberger,et al.  Anatomical abnormalities in the brains of monozygotic twins discordant for schizophrenia. , 1990, The New England journal of medicine.

[95]  A. Heritch,et al.  Evidence for reduced and dysregulated turnover of dopamine in schizophrenia. , 1990, Schizophrenia bulletin.

[96]  G D Pearlson,et al.  Auditory hallucinations and smaller superior temporal gyral volume in schizophrenia. , 1990, The American journal of psychiatry.

[97]  H. Uylings,et al.  Qualitative and quantitative comparison of the prefrontal cortex in rat and in primates, including humans. , 1990, Progress in brain research.

[98]  M S Buchsbaum,et al.  The frontal lobes, basal ganglia, and temporal lobes as sites for schizophrenia. , 1990, Schizophrenia bulletin.

[99]  J. Kleinman,et al.  A quantitative investigation of hippocampal pyramidal cell size, shape, and variability of orientation in schizophrenia. , 1989, Archives of general psychiatry.

[100]  S. Snyder,et al.  Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[101]  B. Hoebel,et al.  Haloperidol given chronically decreases basal dopamine in the prefrontal cortex more than the striatum or nucleus accumbens as simultaneously measured by microdialysis , 1989, Brain Research Bulletin.

[102]  D. Weinberger,et al.  Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. III. A new cohort and evidence for a monoaminergic mechanism. , 1988, Archives of general psychiatry.

[103]  R. Llinás,et al.  The functional states of the thalamus and the associated neuronal interplay. , 1988, Physiological reviews.

[104]  T. Skarsfeldt Differential effects after repeated treatment with haloperidol, clozapine, thioridazine and tefludazine on SNC and VTA dopamine neurones in rats. , 1988, Life sciences.

[105]  A. Scheibel,et al.  Hippocampal pyramidal cell orientation in schizophrenia. A controlled neurohistologic study of the Yakovlev collection. , 1987, Archives of general psychiatry.

[106]  T. Goldberg,et al.  Further evidence for dementia of the prefrontal type in schizophrenia? A controlled study of teaching the Wisconsin Card Sorting Test. , 1987, Archives of general psychiatry.

[107]  C. Blaha,et al.  Chronic haloperidol decreases dopamine release in striatum and nucleus accumbens in vivo: Depolarization block as a possible mechanism of action , 1987, Brain Research Bulletin.

[108]  P. Seeman,et al.  Dopamine receptors and the dopamine hypothesis of schizophrenia , 1987, Synapse.

[109]  A. Scheibel,et al.  Schizophrenia and the hippocampus: the embryological hypothesis extended. , 1987, Schizophrenia bulletin.

[110]  W. Schultz Responses of midbrain dopamine neurons to behavioral trigger stimuli in the monkey. , 1986, Journal of neurophysiology.

[111]  M. Linnoila,et al.  Dopamine metabolism in the cerebrospinal fluid of drug-free schizophrenic patients with and without cortical atrophy. , 1986, Archives of general psychiatry.

[112]  D. Weinberger,et al.  Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. II. Role of neuroleptic treatment, attention, and mental effort. , 1986, Archives of general psychiatry.

[113]  F. Benes,et al.  Quantitative cytoarchitectural studies of the cerebral cortex of schizophrenics. , 1986, Archives of general psychiatry.

[114]  G. E. Alexander,et al.  Parallel organization of functionally segregated circuits linking basal ganglia and cortex. , 1986, Annual review of neuroscience.

[115]  C. Honey,et al.  Ketamine and phencyclidine cause a voltage-dependent block of responses to l-aspartic acid , 1985, Neuroscience Letters.

[116]  B. Bogerts,et al.  Basal Ganglia and Limbic System Pathology in Schizophrenia: A Morphometric Study of Brain Volume and Shrinkage , 1985 .

[117]  G. Mogenson,et al.  Electrophysiological responses of neurones in the nucleus accumbens to hippocampal stimulation and the attenuation of the excitatory responses by the mesolimbic dopaminergic system , 1984, Brain Research.

[118]  A. Scheibel,et al.  A neurohistological correlate of schizophrenia. , 1984, Biological psychiatry.

[119]  F. J. White,et al.  Differential effects of classical and atypical antipsychotic drugs on A9 and A10 dopamine neurons. , 1983, Science.

[120]  B. Bunney,et al.  Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons , 1983, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[121]  P. Bailey The neurobiology of the nucleus accumbens R. B. Chronister and J. F. de France (Eds). Haer Institute for Electrophysiological Research (1981). 388 pp , 1982, Neuroscience.

[122]  I. Feinberg,et al.  Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence? , 1982, Journal of psychiatric research.

[123]  L. Swanson,et al.  A direct projection from Ammon's horn to prefrontal cortex in the rat , 1981, Brain Research.

[124]  F. Owen,et al.  Neurotransmitter receptors in brain in schizophrenia , 1981, Acta psychiatrica Scandinavica. Supplementum.

[125]  L. Judd,et al.  Schizophrenia-like illness following head injury. , 1981, Psychosomatics.

[126]  Douglas L. Jones,et al.  From motivation to action: Functional interface between the limbic system and the motor system , 1980, Progress in Neurobiology.

[127]  A. Grace,et al.  Acute and chronic haloperidol treatment: comparison of effects on nigral dopaminergic cell activity. , 1978, Life sciences.

[128]  D. Hemsley,et al.  The influence of context on language perception in schizophrenia. , 1977, The British journal of social and clinical psychology.

[129]  S H Snyder,et al.  Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs , 1976, Science.

[130]  F. Goodwin,et al.  Cerebrospinal fluid amine metabolites in acute schizophrenia. , 1975, Archives of general psychiatry.

[131]  B. Angrist,et al.  Amphetamine psychosis: behavioral and biochemical aspects. , 1974, Journal of psychiatric research.

[132]  S. Matthysse Antipsychotic drug actions: a clue to the neuropathology of schizophrenia? , 1973, Federation proceedings.

[133]  S. Snyder,et al.  Catecholamines in the brain as mediators of amphetamine psychosis. , 1972, Archives of general psychiatry.

[134]  B. Angrist,et al.  Comparative Psychotomimetic Effects of Stereoisomers of Amphetamine , 1971, Nature.

[135]  R. Herson Mental symptoms in parkinsonian patients treated with L-dopa. , 1970, Lancet.

[136]  L. J. Chapman,et al.  A THEORY OF VERBAL BEHAVIOR IN SCHIZOPHRENIA. , 1964, Progress in experimental personality research.

[137]  B. Maher,et al.  Progress in experimental personality research , 1964 .

[138]  A. Carlsson,et al.  EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN. , 2009, Acta pharmacologica et toxicologica.

[139]  S. Hagiwara,et al.  Electrotonic transmission between two nerve cells in leech ganglion. , 1962, Journal of neurophysiology.

[140]  G. Rosenbaum,et al.  Model psychoses and schizophrenia. , 1962, The American journal of psychiatry.

[141]  G. Rosenbaum,et al.  Comparison of sernyl with other drugs: simulation of schizophrenic performance with sernyl, LSD-25, and amobarbital (amytal) sodium; I. Attention, motor function, and proprioception. , 1959, A.M.A. archives of general psychiatry.

[142]  G. Rosenbaum,et al.  Study of a new schizophrenomimetic drug; sernyl. , 1959, A.M.A. archives of neurology and psychiatry.

[143]  E. Fey The performance of young schizophrenics and young normals on the Wisconsin Card Sorting Test. , 1951, Journal of consulting psychology.

[144]  F. Mott ARCHIVES OF NEUROLOGY AND PSYCHIATRY , 1923 .